Literature DB >> 12181228

Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. ADEnosine Limit myocardial Necrosis.

W J R Desmet, J Dens, P Coussement, F Van de Werf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12181228      PMCID： PMC1767340          DOI： 10.1136/heart.88.3.293

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Preconditioning of human myocardium with adenosine during coronary angioplasty.

Authors:  M A Leesar; M Stoddard; M Ahmed; J Broadbent; R Bolli
Journal:  Circulation       Date:  1997-06-03       Impact factor: 29.690

2.  Measurement of pain.

Authors:  E C Huskisson
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

3.  Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty.

Authors:  M A Karim; M S Shinn; H Oskarsson; J Windle; U Deligonul
Journal:  Am J Cardiol       Date:  1995-09-01       Impact factor: 2.778

4.  Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements.

Authors:  O Johansen; M Brekke; J H Strømme; V Valen; I Seljeflot; O Skjaeggestad; H Arnesen
Journal:  Eur Heart J       Date:  1998-01       Impact factor: 29.983

5.  Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.

Authors:  A E Abdelmeguid; E J Topol; P L Whitlow; S K Sapp; S G Ellis
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690
  5 in total
  6 in total

Review 1.  Statins and their role in pre-percutaneous coronary intervention.

Authors:  Rosetta Melfi; Annunziata Nusca; Giuseppe Patti; Germano Di Sciascio
Journal:  Curr Cardiol Rep       Date:  2010-07       Impact factor: 2.931

Review 2.  Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction.

Authors:  Vijayalakshmi Kunadian; Cafer Zorkun; Scott P Williams; Leah H Biller; Alexandra M Palmer; Katherine J Ogando; Michelle E Lew; Navin Nethala; William J Gibson; Susan J Marble; Jacqueline L Buros; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2008-09-26       Impact factor: 2.300

3.  Current State of the Art in Approaches to Saphenous Vein Graft Interventions.

Authors:  Michael Lee; Jeremy Kong
Journal:  Interv Cardiol       Date:  2017-09

4.  Treating acute "no-reflow" with intracoronary adenosine in 4 patients during percutaneous coronary intervention.

Authors:  Mervyn B Forman; Dongming Hou; Edwin K Jackson
Journal:  Tex Heart Inst J       Date:  2008

5.  Pharmacological prevention of peri-, and post-procedural myocardial injury in percutaneous coronary intervention.

Authors:  Hideki Ishii; Tetsuya Amano; Tatsuaki Matsubara; Toyoaki Murohara
Journal:  Curr Cardiol Rev       Date:  2008-08

6.  The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions.

Authors:  Oyku Gulmez; Ilyas Atar; Bülent Ozin; Mehmet Emin Korkmaz; Asli Atar; Alp Aydinalp; Aylin Yildirir; Haldun Muderrisoglu
Journal:  Vasc Health Risk Manag       Date:  2008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.